References

Bartolo NS, Azzopardi LM, Serracino-Inglot A. Pharmaceuticals and the environment. Early Hum Dev. 2021; 155 https://doi.org/10.1016/j.earlhumdev.2020.105218

Hauser N, Conlon KC, Desai A, Kobziar LN. Climate Change and Infections on the Move in North America. Infect Drug Resist. 2021; 14:5711-5723 https://doi.org/10.2147/IDR.S305077

BBC climate editor made ‘misleading’ weather deaths claim on Panorama. https://www.thetimes.co.uk/article/bbc-climate-editor-made-misleading-weather-deaths-claim-on-panorama-n68b6mplg (accessed 11 May 2022)

Maughan DL, Lillywhite R, Cooke M. Cost and carbon burden of long-acting injections: a sustainable evaluation. Br J Psychol. 2016; 40:132-136 https://doi.org/10.1192/pb.bp.114.049080

McIntyre L. Talking to science deniers and sceptics is not hopeless. Nature. 2021; 596

Quitmann C, Sauerborn R, Danquah I, Herrmann A. ‘Climate change mitigation is a hot topic, but not when it comes to hospitals': a qualitative study on hospital stakeholders’ perception and sense of responsibility for greenhouse gas emissions. J Med Ethics. 2022; 0:1-7 https://doi.org/10.1136/medethics-2021-107971

Taylor GR. The Doomsday Book.London: Book Club Associates; 1972

Climate change and pharmacy

02 June 2022
Volume 4 · Issue 6

Abstract

George Winter discusses how pharmacy services and climate change action must intrinsically work alongside one another and whether it is possible for one to recognise the importance of the other

In my well-thumbed 1972 edition of The Doomsday Book by Taylor (1972), he cites both British physicist John Tyndall, who suggested in 1861 ‘that world temperatures depended on the amount of carbon dioxide present in the atmosphere’, and British climatologist Dr CEP Brooks, who observed in 1949 that ‘[s]ince the beginning of the twentieth-century glaciers have been wasting away rapidly or even catastrophically.’

However, despite these early and subsequent warnings, it is clear from what many describe as our present-day climate change emergency that little has been done to address the onset of climatic havoc. But to what extent has the world of pharmacy paid heed to and/or acted upon the bleak climatic landscape we now survey?

Noting that the NHS is committed to meeting the targets of the Climate Change Act 2008, which includes reducing its carbon footprint by 80% by 2050, Maughan et al (2016) considered the economic cost and carbon footprint associated with prescribing long-term flupentixol decanoate long-acting injections. They found that a reduction of £300 000 could be achieved across England by improving prescribing behaviour, which equates to a saving of £250 per patient per year and 170 000 kg carbon dioxide equivalents. Psychiatrists, they concluded, ‘need to review their prescribing practice of long-acting injections to reduce their impact on the NHS financial budget and the environment.’

Register now to continue reading

Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • New content and clinical newsletter updates each month